(19)
(11)EP 2 890 673 A2

(12)

(88)Date of publication A3:
24.04.2014

(43)Date of publication:
08.07.2015 Bulletin 2015/28

(21)Application number: 13762660.2

(22)Date of filing:  30.08.2013
(51)International Patent Classification (IPC): 
C07C 237/26(2006.01)
C07D 471/04(2006.01)
C07D 295/155(2006.01)
A61P 31/04(2006.01)
C07D 221/18(2006.01)
C07D 207/08(2006.01)
A61K 31/437(2006.01)
(86)International application number:
PCT/US2013/057690
(87)International publication number:
WO 2014/036502 (06.03.2014 Gazette  2014/10)
(84)Designated Contracting States:
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR
Designated Extension States:
BA ME

(30)Priority: 31.08.2012 US 201261695947 P

(71)Applicant: Tetraphase Pharmaceuticals, Inc.
Watertown, MA 02472 (US)

(72)Inventors:
  • XIAO, Xiao-Yi
    Lexington, MA 02421 (US)
  • CLARK, Roger, B.
    Lexington, MA 02421 (US)
  • HUNT, Diana, Katharine
    Cambridge, MA 02139 (US)
  • SUN, Cuixiang
    Watertown, MA 02472 (US)
  • RONN, Magnus
    Melrose, MA 02176-4817 (US)
  • ZHANG, Wu-Yan
    Watertown, MA 02472 (US)
  • HE, Minsheng
    Watertown, MA 02472 (US)

(74)Representative: Snodin, Michael D. 
Park Grove IP Ltd. BioCity Nottingham Pennyfoot Street
Nottingham NG1 1GF
Nottingham NG1 1GF (GB)

  


(54)TETRACYCLINE COMPOUNDS